Ivanti

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where Itron Inc. (NASDAQ:ITRI) stands against the other AI stocks.

Anduril and Microsoft partner to advance the IVAS program, delivering next-gen AR/VR and AI capabilities to the US Army, enhancing battlefield awareness and mission command.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

InterContinental Beverage Capital held its Annual Partners Meeting reflecting on 2024's industry trends and outlining its 2025 strategy. Key insights included the rise of functional beverages, AI's impact,

We recently published a list of 9 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where VEON Ltd. (NASDAQ:VEON) stands against other AI news updates investors should not miss.

We recently published a list of 9 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Viant Technology Inc. (NASDAQ:DSP) stands against other AI news updates investors should not miss.

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

This investment will push Ikonz further as it continues to expand globally, enhance its AI capabilities, and scale its intellectual property (IP) portfolio.